Tempest Therapeutics Inc
Biotechnology
Healthcare
TPST
3.44 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
9.55
52 week high
11.00
high
9.55
52 week low
0.00
low
8.90
growth
43.09 %
previous Close
9.45
P/E ratio
market cap
26.26 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
2234.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top